AstraZeneca’s breast cancer pill gets approval from the FDA
AstraZeneca's breast cancer pill was approved by the FDA, granted in an accelerated process. The FDA's advisory panel had previously voted against the medicine.
AI-generated summary
Read this story on The Seattle Times